Therefore, while targeting the NRF2 pathway may offer therapeutic potential, it is crucial to consider that effective treatment of AD will likely require integrated approaches that address multiple pathological mechanisms simultaneously. The gene discussed is NFE2L2; the disease is Alzheimer disease.